3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
32
Neoplasms
12
Prostatic Neoplasms
10
Carcinoma, Non-Small-Cell Lung
10
Colonic Neoplasms
9
Motor Activity
8
Lung Neoplasms
8
Endometrial Neoplasms
8
Colorectal Neoplasms
8
Uterine Cervical Neoplasms
7
Rectal Neoplasms
7
Obesity
7
Tobacco Use Disorder
6
Small Cell Lung Carcinoma
6
Overweight
6
Pancreatic Neoplasms
5
Leukemia, Myeloid, Acute
5
Breast Carcinoma In Situ
5
Urinary Bladder Neoplasms
4
Ovarian Neoplasms
4
Leukemia
4
Head and Neck Neoplasms
4
Depression
4
Carcinoma, Renal Cell
4
Carcinoma, Intraductal, Noninfiltrating
4
Stomach Neoplasms
3
Sexuality
3
Sexual Dysfunction, Physiological
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Oropharyngeal Neoplasms
3
Interventions
Paclitaxel
11
Carboplatin
8
Radiotherapy
6
Cyclophosphamide
6
Trastuzumab
5
Chemotherapy, Adjuvant
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
Epirubicin
3
Doxorubicin
3
Cryosurgery
3
Cisplatin
3
pertuzumab
2
Surgical Procedures, Operative
2
Radiotherapy, Conformal
2
Radiation
2
Letrozole
2
Lapatinib
2
Cryotherapy
2
Brachytherapy
2
talimogene laherparepvec
1
sargramostim
1
ferric carboxymaltose
1
atezolizumab
1
aldesleukin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Zoledronic Acid
1
Vorinostat
1
VPS Coriolus versicolor extract
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Ductal, Breast
×
Counseling
×
Clear all
NCT01819233
2025-06-06
CAREFOR
Thomas Jefferson University
Phase NA
Completed
38 enrolled
10 charts